News › Clinical Practice, Industry News, News, Patient Care

Injectable Peptide Compounds May Replicate Gastric Bypass Without Nausea Side Effects

June 14, 2023
Needle drawing from vial

A new class of compounds could provide the benefits of gastric bypass surgery without going under the knife, according to research presented at the spring meeting of the American Chemical Society (ACS). The injectable peptide compounds could reduce eating and boost calorie burn while avoiding the side effects of nausea and vomiting that are common with current weight-loss and diabetes drugs.

In rat models, these compound treatments promoted dramatic weight loss and lowered blood glucose. Those benefits are linked to a post-bypass-surgery change in the gut’s secretion levels of certain hormones—including glucagon-like peptide-1 (GLP-1) and peptide YY (PYY)—that signal fullness, curb appetite and normalize blood sugar, according to ACS.

Read more at MedEsthetics >>

Become a member

Get the tools you need to succeed in the medical spa industry.

Related
    • Allergan Aesthetics’ Skinvive by Juvéderm Receives FDA Approval for the Improvement of Neck Appearance
    • Obagi Medical Announces FDA Approval of Obagi saypha ChIQ Injectable Hyaluronic Acid Gel
    • MedSafe Becomes Gold Vendor Affiliate with the American Med Spa Association
    • FDA Approves First New Sunscreen Ingredient in 20 Years
    • Allergan Aesthetics Releases ‘The Aesthetics Evolution: What Consumers Really Want’ Highlighting Consumer Motivations and Expectations in Aesthetics